Cargando…
Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature
Malignant insulinomas are functional neuroendocrine tumors of the pancreas and the primary cause of tumor-related hypoglycemia. Malignant insulinoma is rare and has a poor prognosis. We report a case of metastatic malignant insulinoma in a 64-year-old female patient with severe and refractory hypogl...
Autores principales: | Oziel-Taieb, Sandrine, Maniry-Quellier, Jemima, Chanez, Brice, Poizat, Flora, Ewald, Jacques, Niccoli, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063459/ https://www.ncbi.nlm.nih.gov/pubmed/35518928 http://dx.doi.org/10.3389/fendo.2022.860614 |
Ejemplares similares
-
Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia
por: Siddiqui, Mahwash, et al.
Publicado: (2020) -
SUN-319 Failure Of Pasireotide To Control Hypoglycemia In A Men-1 Patient With Metastatic Insulinoma
por: de Almeida, Tobias, et al.
Publicado: (2019) -
Malignant insulinoma in a patient with hypoglycemia
por: Wang, Tianqi, et al.
Publicado: (2022) -
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study
por: Marx, Mariola, et al.
Publicado: (2023) -
Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia
por: Tarris, Georges, et al.
Publicado: (2023)